Psych Congress 2025

Sept 17 - 21
San Diego, CA

Tardive Dyskinesia

Anatomical Distribution of Involuntary Movements and Clinician-Reported Impact of Tardive Dyskinesia: A Real-World Analysis of the IMPACT-TD Registry

Authors:
Craig Chepke, Stacy Finkbeiner, Martijn Konings, Mark Henegar, Diana Klakotskaia, Winona Tse

Download the poster

Anatomical Distribution of Involuntary Movements and Formal Diagnosis of Tardive Dyskinesia: A Real-World Analysis of the IMPACT-TD Registry

Authors:
Craig Chepke, Stacy Finkbeiner, Martijn Konings, Mark Henegar, Diana Klakotskaia, Winona Tse

Download the poster

Clinical Outcomes of Vesicular Monoamine Transporter 2 Inhibitor Versus Non-Vesicular Monoamine Transporter 2 Inhibitor Treatments Among Patients With Tardive Dyskinesia in Long-Term Care

Authors:
Amber Hoberg, Brittin Wagner, Di Zhang, Maurice T. Driessen, Weixiu Luo, Aaron Norfolk, Kate Mathers, Pooja Gandhi

Download the poster

Patient Experience With Once-Daily Deutetrabenazine Extended-Release Tablets for the Treatment of Tardive Dyskinesia in Individuals With Prior Valbenazine Use

Authors:
Rakesh Jain, Martijn Konings, Maurice T. Driessen, Sameer Kotak, Pooja Gandhi

Download the poster
 

Long Acting Injectable

Pharmacokinetic-Pharmacodynamic Modeling of Switching From Aripiprazole Monohydrate to TV-46000, a Long-Acting Subcutaneous Risperidone, in a Virtual Population of Patients With Schizophrenia

Authors:
Itay Perlstein, Jonathan Meyer, Sharath Kumar, Vijay Ivaturi, Nikita Ramwani, Pavan Rathina Muthu Kumar, Kelli R. Franzenburg, Mark Suett, Rolf Hansen, Avia Merenlender Wagner, Arti Phatak, Rajendra Singh

Download the poster

Inpatient Length of Stay and Healthcare Professional Preferences for Initiating TV-46000, a Long-Acting Subcutaneous Antipsychotic, or Intramuscular Paliperidone Palmitate in Patients Hospitalized With Schizophrenia

Authors:
Ayush Patel, Arti Phatak, Rolf T. Hansen, Julian Casciano, Zenobia Dotiwala, Kelli R. Franzenburg, Mark Suett, Ayelet Yaari

Download the poster

Real-World Experiences Using TV-46000 in Adults With Schizophrenia: A Qualitative Study of Healthcare Professionals

Authors:
Rolf T. Hansen, Arti Phatak, Ayush Patel, Kelli R. Franzenburg, Alison Bulkley, Marc DeCongelio, Zander Pittman, Alex Kissling, Colleen Welsh-Allen

Download the poster

Time-Varying Predictors of Relapse in Patients Treated With TV-46000 or Placebo in the RISE Study A Machine-Learning Analysis

Authors:
Kelli R. Franzenburg, Ying Zhang, Di Zhang, Mark Suett, Rolf Hansen, Arti Phatak, Anna Elgart, Jose M. Rubio

Download the poster

Long-Term Effectiveness With Subcutaneous Long-Acting Injectable Olanzapine (TV-44749) in Adults With SchizophreniaResults From up to 48 Weeks Open-Label Treatment in the Phase 3 SOLARIS Trial

Authors:
Christoph U. Correll, Ken Shulman, Tamar Bar-Nur, Rotem Gidron-Budovsky, Nir Sharon, Ayellet Jehassi, Kelli R. Franzenburg, Mark Suett, Ortal Pelleg, Helena Knebel, Avia Merenlender-Wagner, Eran Harary, Anna Elgart

Download the poster

Long-Term Safety of Subcutaneous Long-Acting Injectable Olanzapine (TV-44749) in Schizophrenia: Results From the Phase 3 SOLARIS Trial

Authors:
Christoph U. Correll, Ken Shulman, Tamar Bar-Nur, Rotem Gidron-Budovsky, Nir Sharon, Ayellet Jehassi, Kelli R. Franzenburg, Mark Suett, Ortal Pelleg, Helena Knebel, Avia Merenlender-Wagner, Eran Harary, Anna Elgart

Download the poster

Evaluating Long-Term Weight Gain and Other Metabolic Changes With Subcutaneous Long-Acting Injectable Olanzapine (TV-44749) in Adults With Schizophrenia Results From the Phase 3 SOLARIS Trial

Authors:
Christoph U. Correll, Ken Shulman, Tamar Bar-Nur, Rotem Gidron-Budovsky, Nir Sharon, Ayellet Jehassi, Kelli R. Franzenburg, Mark Suett, Ortal Pelleg, Helena Knebel, Avia Merenlender-Wagner, Eran Harary, Anna Elgart

Download the poster

Clinician Perspectives on Olanzapine-Associated Adverse Event Mitigation Strategies for Schizophrenia Treatment Results From the SONAR (Survey on Olanzapine Needs and Attitudes Research) Study

Authors:
Rolf Hansen, Arti Phatak, Greg Salinas, Emily Belcher, Brandon Coleman, Andrew J. Cutler, Peter J. Weiden, Mark Suett, Kelli R. Franzenburg

Download the poster

Clinician Perspectives on Long-Acting Injectable Olanzapine Treatment Barriers and Unmet Needs From the SONAR (Survey on Olanzapine Needs and Attitudes Research) Study

Authors:
Rolf Hansen, Arti Phatak, Greg Salinas, Emily Belcher, Brandon Coleman, Andrew J. Cutler, Peter J. Weiden, Mark Suett, Kelli R. Franzenburg

Download the poster

Real-World Evidence of the Burden of Non-Adherence to Oral Olanzapine on Relapse and Healthcare Resource Utilization Among Adults With Schizophrenia

Authors:
M. Kane, Sangtaeck Lim Handing Xie, Mark Suett, Kelli R. Franzenburg, Rolf Hansen, Amit Kumar, Jose M. Rubio

Download the poster